Comparative Study of Intestinal Color Ultrasound and Capsule Endoscopy in Monitoring Crohn's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-30

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The disease activity index under intestinal color ultrasound was evaluated by SUS-CD, and the disease activity index under capsule endoscopy was evaluated by CECDAI. All subjects underwent intestinal color ultrasound and capsule endoscopy at baseline and at the third month of treatment. To compare the correlation between SUS-CD and CECDAI before and after treatment, and to compare the role of intestinal color ultrasound and capsule endoscopy in monitoring Crohn's disease in small intestine.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Contrast Ultrasound of the Small Intestine in Patients With Crohns Disease

NCT01365767

Crohn Disease

COMPLETED

Correlation of Cross Sectional Imaging and Small Intestinal Contrast Ultrasonography in Known Crohn's Disease

NCT06125678

Crohn Disease Ultrasound Therapy; Complications Computed Tomography +1 more

COMPLETED NA

Contrast-enhanced Ultrasound in Patients With Crohn´s Disease and Food Allergy

NCT05768971

Crohn Disease Food Allergy

COMPLETED

Upper Gastrointestinal Lesions in Crohn's Disease

NCT03524144

Upper Gastrointestinal Lesions Crohn's Disease

UNKNOWN NA

A Comparative Study of Capsule Endoscopy, Magnetic Resonance Imaging and Computer Tomography Scanning of the Small Bowel in Crohn's Disease

NCT01019460

Crohn's Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The disease activity index under intestinal color ultrasound was evaluated by SUS-CD, and the disease activity index under capsule endoscopy was evaluated by CECDAI. Active lesions under intestinal color ultrasound were defined as SUS-CD ≥ 1, and active lesions under capsule endoscopy were defined as CECDAI ≥ 3.9. All subjects underwent intestinal color ultrasound and capsule endoscopy at baseline and 3 months after treatment. To compare the correlation between SUS-CD and CECDAI before and after treatment, and to compare the role of intestinal color ultrasound and capsule endoscopy in monitoring Crohn's disease in small intestine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Digestive System Disease Inflammatory Bowel Diseases Crohn Disease Crohn Disease of Small Intestine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1.Patients diagnosed with Crohn's disease according to the 2019 European Guidelines for Crohn's disease;
* 2.At the time of inclusion, there were active lesions under color ultrasound or capsule endoscopy;
* 3.Voluntarily sign an informed consent form.